The role of NNRTIs in antiretroviral combination therapy: An introduction

Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents, http://www.hivatis.org (accessed 5 February 2001)

BHIVA Writing Committee on behalf of the BHIVA Executive Committee. British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy. HIV Med 2000;1:76101. BHIVA Guidelines, issued December 1999. [http://www.aidsmap.com/bhiva/bhivagd1299.htm (accessed 14 December 2000)]

Tashima K , Staszewski S , Morales-Ramirez JO Efavirenz (EFV) + zidovudine (ZDV) + lamivudine (3TC) provides superior long-term HIV-RNA suppression, antiretroviral activity and tolerability versus indinavir (IDV) +ZDV + 3TC: results of Study 006 at 72 weeks (initial cohort). 37th Annual Meeting of the Infectious Diseases Society of America. Philadelphia, USA, November 1999. Abstract 366

Nelson M , Staszewski S , Morales-Ramirez JO Successful virologie suppression with efavirenz in HIV-infected patients with low baseline CD4 cell counts: post-hoc results from Study 006. 10th European Congress of Clinical Microbiology and Infectious Diseases. Stockholm, Sweden, May 2000. Abstract 3-349

Staszewski S , Keiser P , Montaner J Abacavir-lamivudine-zidovudine vs indinavir-lamivudine-zidovu-dine in antiretroviral-naïve HIV-infected adults. JAMA 2001;285:115563

Cahn P . Preliminary efficacy, adherence and satisfaction with COM/ABC versus COM/IDV, an open-label randomised comparative study (CNAB3014). 13th International AIDS Conference. Durban, South Africa, July 2000. Abstract WeOrB606

Sabin C , Matthews G , Mandalia S , Phillips A , Johnson M , Gazzard B . A comparison of initial treatment regimens in antiretroviral-naïve patients starting HAART. 1st IAS Conference on HIV Pathogenesis and Treatment. Buenos Aires, Argentina, July 2001. Abstract 241

Phillips AN , Pradier C , Lazzarin B HIV viral load outcome of non-nucleoside reverse transcriptase inhibitor-containing regimens for 2203 mainly antiretroviral-experienced patients. 8th Conference on Retroviruses and Opportunistic Infections. Chicago, Illinois, February 2001. Abstract 234

Moyle GJ , Wilkins E , Leen C , Cheesbrough A , Reynolds B , Gazzard BG . Salvage therapy with abacavir plus efavirenz or nevirapine in HIV-l-infected persons with previous nucleoside analogue and protease inhibitor use. AIDS 2000;14:14534